A randomized controlled trial of stereotactic body radiation therapy (SBRT) with radiofrequency ablation (RFA) for small hepatocellular carcinoma
Phase 3
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000002488
- Lead Sponsor
- Department of Gastroenterology, National Hospital Organization, Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 288
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Active infectious disease requiring treatment (2) In pregnancy or lactation, or with expectation of pregnancy (3) History of irradiation to body trunk for any disease (4) Implantation of a permanent pacemaker (5) Tumors abutting the stomach or intestinal loop (6) Simultaneous malignancies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Three-year survival
- Secondary Outcome Measures
Name Time Method Three-year local tumor control rate Incidence of adverse events